给婴儿用干细胞?新生儿科医生与家长对优化临床试验的看法
这项定性研究通过对18名极早产儿家长和16名新生儿科医生的半结构化访谈,识别了间充质基质细胞治疗支气管肺发育不良临床试验的参与障碍与促进因素。家长的主要障碍包括对临床试验流程、干细胞及风险副作用缺乏了解,且家长更希望由新生儿科医生在分娩前或出生后1-2周直接招募。多数新生儿科医生认为招募家长不属于其职责,并报告竞争性优先事项、时间投入、成本和缺乏机构支持是重要障碍。
要点
- 家长希望由新生儿科医生在分娩前或出生后1-2周直接招募参与干细胞临床试验。
- 家长对临床试验流程和干细胞风险副作用缺乏了解是主要参与障碍。
- 多数新生儿科医生认为招募家长不属于其职责且面临时间成本等障碍。
核心结论
- 早期整合利益相关者有助于识别并解决间充质基质细胞治疗临床试验入组的重要障碍。
- 部分已识别的障碍是未预料到的,若未发现可能影响招募。
- 该方法可更广泛地用于其他儿科早期临床试验。
研究设计与样本
- 定性研究,对18名极早产儿家长和16名新生儿科医生进行一对一半结构化访谈。
- 访谈指南和定向内容分析以理论域框架为基础,该框架为实施研究工具用于识别行为影响因素。
主要发现
- 家长的主要障碍包括缺乏对临床试验流程的一般知识、对干细胞缺乏了解以及对风险和副作用的担忧。
- 家长更倾向于由新生儿科医生在分娩前或出生后1或2周直接招募。
- 多数新生儿科医生认为招募家长不属于其角色。
- 新生儿科医生报告竞争性优先事项、时间投入、成本和缺乏机构支持是招募患者的重要障碍。
临床怎么用
- 在设计儿科早期干细胞临床试验时,应早期纳入家长和新生儿科医生以识别并解决入组障碍。
- 可考虑由新生儿科医生在分娩前或出生后1-2周直接向家长介绍试验。
- 需关注新生儿科医生的时间、成本和机构支持等障碍以促进招募。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify barriers and enablers that may influence parents' and neonatologists' participation in clinical trials of mesenchymal stromal cells for bronchopulmonary dysplasia. STUDY DESIGN: This qualitative study involved one-on-one semistructured interviews with parents of extremely preterm infants (n = 18) and neonatologists (n = 16). Interview guides and directed content analysis were framed using the theoretical domains framework, a tool specifically developed for implementation research to identify influences on behavior. RESULTS: Key barriers for parents included their lack of knowledge about clinical trial processes in general, stem cells, and concerns about their risks and side effects. Importantly, parents preferred to be approached for recruitment directly by a neonatologist, either before delivery or 1 or 2 weeks after birth. However, the majority of neonatologists felt that approaching parents was not part of their role. Neonatologists reported competing priorities, time commitment, costs, and lack of institutional support as significant barriers to their ability to recruit patients. CONCLUSIONS: By integrating stakeholders early into the development of a clinical trial of mesenchymal stromal cell therapy, we identified and can address important barriers to enrollment. Some identified barriers were unanticipated and could have compromised recruitment had they not been identified by this study. We suggest that this approach can be used more broadly for other early phase clinical trials in pediatrics.
引用
- Guillot M, Asad S, Lalu MM, et al. So You Want to Give Stem Cells to Babies? Neonatologists and Parents' Views to Optimize Clinical Trials. J Pediatr. 2019. PMID: 31005276. doi:10.1016/j.jpeds.2019.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。